User:Mr. Ibrahem/Pneumococcal vaccine

Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae, to protect from pneumococcal infection. Their use can prevent some cases of pneumonia, meningitis, and sepsis. There are two types of pneumococcal vaccines: conjugate vaccines and polysaccharide vaccines. They are given by injection either into a muscle or just under the skin.

The World Health Organization (WHO) recommends the use of the conjugate vaccine in the routine immunizations given to children. This includes those with HIV/AIDS. The recommended three or four doses are between 71 and 93% effective at preventing severe pneumococcal disease. The polysaccharide vaccines, while effective in healthy adults, are not effective in children less than two years old or those with poor immune function.

These vaccines are generally safe. With the conjugate vaccine about 10% of babies develop redness at the site of injection, fever, or change in sleep. Severe allergies are very rare.

The first pneumococcal vaccine was developed in the 1980s. It is on the World Health Organization's List of Essential Medicines. The wholesale cost in the developing world is about US$17 per dose as of 2014. In the United States it is between US$25 and US$100. 138 countries had introduced the vaccine into routine schedules by 2018.